Floatz logo

Busulphan

SHR2554

The First Affiliated Hospital of Soochow UniversityPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
81/ 100

Competitive context

9 Active assets in the SHR2554 cohort.

Asset / SponsorPhaseRating
shr2554
The First Affiliated Hospital of Soochow University
Phase 2CCC
Cyclophosphamide
The First Affiliated Hospital of Soochow University
Phase 2CCC
Azacitidine
The First Affiliated Hospital of Soochow University
Phase 2CCC
Anti-Thymoglobulin, Rabbit
The First Affiliated Hospital of Soochow University
Phase 2CCC
METHOTREXATE
The First Affiliated Hospital of Soochow University
Phase 2CCC

View all 9 →

Same molecule, other indications

Busulphan is also rated in:

plasma cell myelomaDormant
BBB
Indicative ·
77 / 100
View asset →
myelodysplastic/myeloproliferative neoplasmDormant
BBB
Indicative ·
76 / 100
View asset →
graft versus host diseaseDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →